IL102058A - תולדות פירימידין נוקלאוסיד כגורם להפחתת ליפידים - Google Patents
תולדות פירימידין נוקלאוסיד כגורם להפחתת ליפידיםInfo
- Publication number
- IL102058A IL102058A IL10205892A IL10205892A IL102058A IL 102058 A IL102058 A IL 102058A IL 10205892 A IL10205892 A IL 10205892A IL 10205892 A IL10205892 A IL 10205892A IL 102058 A IL102058 A IL 102058A
- Authority
- IL
- Israel
- Prior art keywords
- active ingredient
- propynyluracil
- arabinofuranosyl
- pharmaceutically acceptable
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919111580A GB9111580D0 (en) | 1991-05-30 | 1991-05-30 | Nucleoside derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL102058A0 IL102058A0 (en) | 1992-12-30 |
| IL102058A true IL102058A (he) | 1996-07-23 |
Family
ID=10695778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10205892A IL102058A (he) | 1991-05-30 | 1992-05-29 | תולדות פירימידין נוקלאוסיד כגורם להפחתת ליפידים |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5432166A (he) |
| EP (1) | EP0542952B1 (he) |
| JP (1) | JPH06500129A (he) |
| AT (1) | ATE142501T1 (he) |
| AU (1) | AU657756B2 (he) |
| CA (1) | CA2088264A1 (he) |
| DE (1) | DE69213660D1 (he) |
| GB (1) | GB9111580D0 (he) |
| HU (1) | HUT63767A (he) |
| IE (1) | IE921731A1 (he) |
| IL (1) | IL102058A (he) |
| MX (1) | MX9202595A (he) |
| WO (1) | WO1992021352A1 (he) |
| ZA (1) | ZA923962B (he) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
| US20040033267A1 (en) * | 2002-03-20 | 2004-02-19 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
| US20030054042A1 (en) * | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
| SG11201402826YA (en) | 2011-12-22 | 2014-12-30 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2244328A1 (de) * | 1972-09-09 | 1974-03-21 | Boehringer Mannheim Gmbh | Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben |
| US4594339A (en) * | 1982-04-06 | 1986-06-10 | Sloan-Kettering Institute For Cancer Research | Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides |
| IT1196261B (it) * | 1984-09-20 | 1988-11-16 | Pierrel Spa | Derivati nucleosidici e purinici 8-sostituiti |
| US5063233A (en) * | 1986-11-14 | 1991-11-05 | Ciba-Geigy Corporation | N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists |
| GB8629892D0 (en) * | 1986-12-15 | 1987-01-28 | Wellcome Found | Antiviral compounds |
| HU198950B (en) * | 1986-12-15 | 1989-12-28 | Sandoz Ag | Process for producing new furanuronic acid derivatives and pharmaceutical compositions comprising such compounds |
| EP0277917A3 (en) * | 1987-02-04 | 1990-03-28 | Ciba-Geigy Ag | Certain adenosine 5'-carboxamide derivatives |
| US4962194A (en) * | 1987-04-02 | 1990-10-09 | Warner-Lambert Company | Method of preparing 51,N6-disubstituted adenosines from inosines |
| US5028596A (en) * | 1987-12-14 | 1991-07-02 | Burroughs Wellcome Co. | 1-(β-D-arabinofuranosyl)-5-propynyluracil for treatment of VZV infections |
| GB8729994D0 (en) * | 1987-12-23 | 1988-02-03 | Glaxo Group Ltd | Chemical compounds |
| AU3820989A (en) * | 1988-08-02 | 1990-02-08 | Ciba-Geigy Ag | 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives |
| GB2226027B (en) * | 1988-12-13 | 1992-05-20 | Sandoz Ltd | Adenosine derivatives,their production and use |
| JPH03287537A (ja) * | 1990-03-31 | 1991-12-18 | Yamasa Shoyu Co Ltd | 抗動脈硬化症剤 |
| FR2665362B1 (fr) * | 1990-08-03 | 1994-12-09 | Cepbepe | Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application. |
-
1991
- 1991-05-30 GB GB919111580A patent/GB9111580D0/en active Pending
-
1992
- 1992-05-29 HU HU9300243A patent/HUT63767A/hu unknown
- 1992-05-29 DE DE69213660T patent/DE69213660D1/de not_active Expired - Lifetime
- 1992-05-29 US US07/988,122 patent/US5432166A/en not_active Expired - Fee Related
- 1992-05-29 CA CA002088264A patent/CA2088264A1/en not_active Abandoned
- 1992-05-29 MX MX9202595A patent/MX9202595A/es unknown
- 1992-05-29 ZA ZA923962A patent/ZA923962B/xx unknown
- 1992-05-29 EP EP92910638A patent/EP0542952B1/en not_active Expired - Lifetime
- 1992-05-29 AT AT92910638T patent/ATE142501T1/de not_active IP Right Cessation
- 1992-05-29 AU AU17673/92A patent/AU657756B2/en not_active Ceased
- 1992-05-29 JP JP4509647A patent/JPH06500129A/ja active Pending
- 1992-05-29 WO PCT/GB1992/000971 patent/WO1992021352A1/en active IP Right Grant
- 1992-05-29 IL IL10205892A patent/IL102058A/he active IP Right Grant
- 1992-07-01 IE IE173192A patent/IE921731A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0542952A1 (en) | 1993-05-26 |
| IL102058A0 (en) | 1992-12-30 |
| GB9111580D0 (en) | 1991-07-24 |
| HU9300243D0 (en) | 1993-04-28 |
| CA2088264A1 (en) | 1992-12-01 |
| WO1992021352A1 (en) | 1992-12-10 |
| HUT63767A (en) | 1993-10-28 |
| EP0542952B1 (en) | 1996-09-11 |
| ZA923962B (en) | 1993-11-29 |
| DE69213660D1 (de) | 1996-10-17 |
| JPH06500129A (ja) | 1994-01-06 |
| US5432166A (en) | 1995-07-11 |
| IE921731A1 (en) | 1992-12-02 |
| AU1767392A (en) | 1993-01-08 |
| MX9202595A (es) | 1992-11-01 |
| AU657756B2 (en) | 1995-03-23 |
| ATE142501T1 (de) | 1996-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5079235A (en) | Antiviral compounds | |
| KR20020031331A (ko) | 미토콘드리아 관련 질환의 치료방법 | |
| TW201622728A (zh) | 全身紅斑性狼瘡之治療 | |
| US5432166A (en) | Use of 1-(β-D-arabinofuranosyl) -5-propynyluracil for lowering serum cholesterol | |
| US20070225339A1 (en) | Compositions and methods for treating rheumatoid arthritis | |
| US5432165A (en) | Methods for the treatment of infection caused by Hepatitis B virus (HBV) | |
| EP0509752B1 (en) | Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist | |
| AU755633B2 (en) | Antiviral combinations | |
| US5504093A (en) | Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication | |
| US7354906B2 (en) | Composition of anti-HIV drugs and anti-cortisol compounds and method for decreasing the side effects of anti-HIV drugs in a human | |
| US6432966B2 (en) | Antiviral combinations | |
| EP0253517B1 (en) | Use of 3'azido-3'deoxythymidine for the manufacture of a medicament for the treatment of giardiasis | |
| GB2197588A (en) | Immunoregulator comprising a derivative of estradiol | |
| AU620471B2 (en) | Antiviral 5-propynyl pyrimidine nucleosides | |
| DE4204108C2 (de) | Arzneimittel zur Behandlung und/oder Prophylaxe von Störungen des Folat-Stoffwechsels | |
| AU8349498A (en) | Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) | |
| US5028596A (en) | 1-(β-D-arabinofuranosyl)-5-propynyluracil for treatment of VZV infections | |
| WO2000003717A1 (en) | Method of treatment | |
| Veng‐Pedersen et al. | A system approach to pharmacodynamics. Plasma iron mobilization by endogenous erythropoietin in the sheep fetus; evidence of threshold response in spontaneous hypoxemia | |
| EP1019056A1 (en) | Antiviral combinations containing the carbocyclic nucleoside 1592u89 | |
| JPS59184147A (ja) | 痙れん防止性を有する化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted |